Table 1B.
Characteristics of the study population.
| N | Total IgE (IU/ml) | % FVC | % FVE1 | % Eosinophils | Eosinophils count (cells/μl) | |
|---|---|---|---|---|---|---|
| (B) CHARACTERISTICS OF THE POPULATION ACCORDING TO ASTHMA SEVERITY | ||||||
| Severe NA subjects |
15 | 88.85 ± 61.57 | 69.93 ± 19.94 | 66.33 ± 16.62 | 3.73 ± 2.48 | 264.00 ± 152.96 |
| Moderate/mild NA subjects |
15 | 75.24 ± 97.87 | 94.00 ± 19.52# | 85.38 ± 21.03* | 4.22 ± 1.25 | 310.00 ± 52.57 |
| Severe AA subjects |
15 | 306.27 ± 204.53 | 71.93 ± 12.38 | 69.27 ± 13.36 | 5.89 ± 3.70 | 739.50 ± 1180.74 |
| Moderate/mild AA subjects |
15 | 417.13 ± 583.84 | 79.13 ± 19.70 | 77.40 ± 18.31 | 5.28 ± 2.85 | 359.83 ± 220.55 |
NA, nonallergic asthmatic; AA, allergic asthmatic; % FVC, percentage of predicted value of forced vital capacity; % FEV1, percentage of predicted value of forced expiratory volume in 1 second.
*
Statistically significant comparison (p < 0.05) between the severe NA and moderate/mild NA group.
#
Statistically significant comparison (p < 0.005) between the severe NA and moderate/mild NA group.